Literature DB >> 18550741

Evaluation of linear array human papillomavirus genotyping using automatic optical imaging software.

J Jeronimo1, N Wentzensen, R Long, M Schiffman, S T Dunn, R A Allen, J L Walker, M A Gold, R E Zuna, M E Sherman, S Wacholder, S S Wang.   

Abstract

Variations in biological behavior suggest that each carcinogenic human papillomavirus (HPV) type should be considered individually in etiologic studies. HPV genotyping assays might have clinical applications if they are approved for use by the FDA. A widely used genotyping assay is the Roche Linear Array HPV genotyping test (LA). We used LA to genotype the HPV isolates from cervical specimens from women with the full spectrum of cervical disease: cervical cancer, cervical intraepithelial neoplasia (CIN), and HPV infections. To explore the feasibility and value of the automated reading of the LA results, we custom-designed novel, optical imaging software that provides optical density measurements of LA bands. We compared unmagnified visual examination with the automated measurements. The two measurements were highly associated. By either method, the threshold between a negative and a positive result was fairly sharp, with a clear bimodal distribution. Visually, most positive results were judged to be strong or medium, with fewer equivocal results categorized as weak (9.5% of positive samples), very weak (6.5% of positive samples), or extremely weak (7.7% of positive samples). The automated measurements of the intensities were significantly associated with the strength of the visual categories (P < 0.001). At the extremes of the automated signal intensities (< or = 20 units or > or = 120 units), the bands were almost always categorized visually as negative and positive, respectively. In the equivocal zone (20 to 119 units), specimens were more increasingly likely to be judged to be visually positive as the number of other, definite infections on the same strip increased (P for trend < 0.001). Multiple, concurrent infections comprise > or = 25% of HPV infections; thus, any systematic visual tendency that influences their evaluation when the result is equivocal should be minimized. Therefore, automated reading is probably worth development if easy-to-calibrate hardware and software can be optimized.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550741      PMCID: PMC2519466          DOI: 10.1128/JCM.00188-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods.

Authors:  S Terence Dunn; Richard A Allen; Sophia Wang; Joan Walker; Mark Schiffman
Journal:  J Virol Methods       Date:  2007-03-30       Impact factor: 2.014

2.  Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

Authors:  Melinda Butsch Kovacic; Philip E Castle; Rolando Herrero; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Ana C Rodriguez; Martha L Hutchinson; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Robert D Burk
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

3.  Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines.

Authors:  Fabian Mendez; Nubia Munoz; Hector Posso; Monica Molano; Victor Moreno; Adrian J C van den Brule; Margarita Ronderos; Chris Meijer; Alvaro Munoz
Journal:  J Infect Dis       Date:  2005-08-29       Impact factor: 5.226

4.  ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.

Authors:  M Schiffman; M E Adrianza
Journal:  Acta Cytol       Date:  2000 Sep-Oct       Impact factor: 2.319

5.  Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.

Authors:  Rolando Herrero; Philip E Castle; Mark Schiffman; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Sabrina Chen; Ana C Rodriguez; Robert D Burk
Journal:  J Infect Dis       Date:  2005-05-02       Impact factor: 5.226

6.  A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.

Authors:  Martyn Plummer; Mark Schiffman; Philip E Castle; Delphine Maucort-Boulch; Cosette M Wheeler
Journal:  J Infect Dis       Date:  2007-04-16       Impact factor: 5.226

7.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

Review 8.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

9.  Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Philip E Castle; Diane Solomon; Robert Burk
Journal:  J Natl Cancer Inst       Date:  2008-03-25       Impact factor: 13.506

10.  Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type.

Authors:  Jose Jeronimo; L Stewart Massad; Mark Schiffman
Journal:  Am J Obstet Gynecol       Date:  2007-07       Impact factor: 8.661

View more
  6 in total

1.  Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test.

Authors:  Matthew P Stevens; Suzanne M Garland; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

2.  Reproducibility of linear array for human papillomavirus genotyping.

Authors:  Jill Koshiol; S Terence Dunn; Joan L Walker; Rosemary E Zuna; Mark Schiffman; Mark E Sherman; Michael A Gold; Richard A Allen; Roy Zhang; Sophia S Wang; Nicolas Wentzensen
Journal:  J Clin Microbiol       Date:  2012-11-28       Impact factor: 5.948

3.  Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing.

Authors:  Sarah Wagner; David Roberson; Joseph Boland; Meredith Yeager; Michael Cullen; Lisa Mirabello; S Terence Dunn; Joan Walker; Rosemary Zuna; Mark Schiffman; Nicolas Wentzensen
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

4.  Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens.

Authors:  Nicolas Wentzensen; Patti E Gravitt; Rodney Long; Mark Schiffman; S Terence Dunn; J Daniel Carreon; Richard A Allen; Munira Gunja; Rosemary E Zuna; Mark E Sherman; Michael A Gold; Joan L Walker; Sophia S Wang
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

5.  Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma.

Authors:  Nicolas Wentzensen; Mark Schiffman; S Terence Dunn; Rosemary E Zuna; Joan Walker; Richard A Allen; Roy Zhang; Mark E Sherman; Sholom Wacholder; Jose Jeronimo; Michael A Gold; Sophia S Wang
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

6.  Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.

Authors:  Nicolas Wentzensen; Mark Schiffman; Terence Dunn; Rosemary E Zuna; Michael A Gold; Richard A Allen; Roy Zhang; Mark E Sherman; Sholom Wacholder; Joan Walker; Sophia S Wang
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.